This is a preview.
Sign in or create a free account to view the full dataset, chart and data table.
Sign in or create a free account to view this dataset's chart and data table.
Key Takeaway
- Ear, nose and throat medicines recorded a CAGR of 5% between FY 2019–20 and FY 2024–25. The category primarily covers aural preparations. This positive growth rate indicates steady expansion in reported sales, although the available CAGR alone does not establish changes in underlying demand.
About This Dataset
Annual sales data for animal health ear, nose and throat preparations, covering aural products used primarily for ear-related conditions and associated treatment requirements in animals. The dataset presents aggregated sales by financial year from 1 July to 30 June.
Methodology
Sign in or create a free account to view this dataset's methodology and sources.
You have subscriber access to this dataset
Available formats: Excel, CSV, PNG, PDF.
A downloadable report hasn't been published for this dataset yet.
View Subscription Plans
Request Demo
ENTERPRISE ACCESS
Transform Data Into Better Business Decisions
Join organizations that rely on statSCALAR for trusted market intelligence, industry statistics, commodity insights and enterprise research.
100+
Industries Included
150+
Countries
50K+
Data Points
24×7
Enterprise Access